Phocas Financial’s Zevra Therapeutics ZVRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-295,907
Closed -$4.24M – 146
2026
Q2
$4.24M Buy
295,907
+136,484
+86% +$1.52M 0.59% 73
2026
Q1
$1.49M Buy
+159,423
New +$1.44M 0.23% 118

Other funds holding ZVRA

Phocas Financial's ZVRA Position: Q3 2026 in Review

Phocas Financial sold out of Zevra Therapeutics (ZVRA) in Q3 2026, closing a stake of 295,907 shares — an estimated $4.24M sold.

Phocas Financial first reported a position in ZVRA in Q1 2026 and held it in 2 quarters. The position peaked at $4.24M in Q2 2026. 129 funds tracked by Wall St. Rank hold ZVRA as of Q3 2026.

  • Phocas Financial reported no remaining Zevra Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Phocas Financial sold 295,907 Zevra Therapeutics shares in Q3 2026, an estimated $4.24M.
  • Phocas Financial first reported a position in Zevra Therapeutics in Q1 2026 and held it in 2 quarters.
  • Phocas Financial's Zevra Therapeutics position peaked at $4.24M in Q2 2026.
  • 129 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q3 2026.

Based on Phocas Financial's 13F filing for Q3 2026.